Tumor-Infiltrating Lymphocytes in the Treatment of Solid Tumors - Episode 5

Clinical Trial Data on TILs in Non-Small Cell Lung Cancer (NSCLC)

In the second installment of the series, Ben Creelan, MD, reviews clinical trial data and explains the rationale of using tumor-infiltrating lymphocytes (TILs) in non-small cell lung cancer (NSCLC) treatment.